Blood advances

· 4 papers in corpus
other 2026
doi:10.1182/bloodadvances.2025018315 ·PMID:41504430

Iron-deficiency anemia (IDA) affects nearly one-third of women globally, with heavy menstrual bleeding (HMB) being a significant risk factor among those of reproductive age. Despite the substantial burden of HMB-related IDA, patients often …

observational 2023
doi:10.1182/bloodadvances.2021005557 ·PMID:36129842

Preservation of fertility has become a growing concern in young females with Hodgkin lymphoma (HL). However, the rate of pregnancy after the current most frequently prescribed ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, and darc…

guideline 2021
doi:10.1182/bloodadvances.2020003264 ·PMID:33570647

BACKGROUND: von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients. OBJECTIVE: These evidence-based guidelines from the American Society of Hematology …

guideline 2019
doi:10.1182/bloodadvances.2019000966 ·PMID:31794604

BACKGROUND: Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE: These…